Literature DB >> 7125073

Management of medullary carcinoma of the thyroid.

W J Simpson, J A Palmer, I B Rosen, R A Mustard.   

Abstract

Total thyroidectomy is universally advised for the familial variety of MCT. Although total thyroidectomy is also recommended for sporadic cases, partial thyroidectomy may be adequate. Cervical and upper mediastinal nodes should be sampled for microscopic study, even when they are small and appear to be normal. Appropriate neck or mediastinal nodes should be sampled for microscopic study, even when they are small and appear to be normal. Appropriate neck or mediastinal dissection is done if metastasis is present. External radiation is a valuable adjuvant to surgical excision following the apparent complete resection of the tumor, and is beneficial in the management of unresectable disease. Despite local control, patients continue to die from disseminated disease; therefore, there must be a continued search for an effective chemotherapeutic program. Much remains to be learned from calcitonin monitoring of MCT patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7125073     DOI: 10.1016/0002-9610(82)90415-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

1.  Prognostic factors for sporadic medullary thyroid carcinoma.

Authors:  Kaptan Gülben; Uğur Berberoğlu; Mustafa Boyabatli
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

2.  Medullary carcinoma of the thyroid with axillary metastasis: a case report.

Authors:  Murat Ozdemir; Ozer Makay; Ilgin Simsir; Yeşim Ertan; Gokhan Icoz; Füsun Saygili; Mahir Akyildiz
Journal:  Int Surg       Date:  2015-03

Review 3.  Surgical strategy for the treatment of medullary thyroid carcinoma.

Authors:  J B Fleming; J E Lee; M Bouvet; P N Schultz; S I Sherman; R V Sellin; K E Friend; M A Burgess; G J Cote; R F Gagel; D B Evans
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

4.  Leu-M1 immunoreactivity and prognosis in medullary carcinomas of the thyroid gland.

Authors:  S Schröder; W Schwarz; W Rehpenning; H Dralle; V Bay; W Böcker
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

5.  Markov model-based estimation of individual survival probability for medullary thyroid cancer patients.

Authors:  Olga Esik; Gábor Tusnády; Lajos Trón; András Boér; Zoltán Szentirmay; István Szabolcs; Károly Rácz; Erzsébet Lengyel; Judit Székely; Miklós Kásler
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

6.  Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register.

Authors:  F Raue; J Kotzerke; D Reinwein; S Schröder; H D Röher; H Deckart; R Höfer; M Ritter; F Seif; H Buhr
Journal:  Clin Investig       Date:  1993-01

7.  Total thyroidectomy. A review of 213 patients.

Authors:  J K Jacobs; J W Aland; J F Ballinger
Journal:  Ann Surg       Date:  1983-05       Impact factor: 12.969

Review 8.  Medullary thyroid cancer.

Authors:  E Kebebew; O H Clark
Journal:  Curr Treat Options Oncol       Date:  2000-10

9.  Treatment of medullary carcinoma of the thyroid by laryngo-pharyngo-oesophagectomy--a case report.

Authors:  S Pender; D M Little; P Burke; P Broe
Journal:  Ir J Med Sci       Date:  1992-07       Impact factor: 1.568

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.